Sutro Biopharma (STRO) Enterprise Value (2017 - 2025)
Historic Enterprise Value for Sutro Biopharma (STRO) over the last 9 years, with Q3 2025 value amounting to -$167.6 million.
- Sutro Biopharma's Enterprise Value rose 5683.39% to -$167.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$167.6 million, marking a year-over-year increase of 5683.39%. This contributed to the annual value of -$316.9 million for FY2024, which is 503.06% up from last year.
- As of Q3 2025, Sutro Biopharma's Enterprise Value stood at -$167.6 million, which was up 5683.39% from -$205.1 million recorded in Q2 2025.
- Sutro Biopharma's Enterprise Value's 5-year high stood at -$160.8 million during Q4 2021, with a 5-year trough of -$388.3 million in Q3 2024.
- For the 5-year period, Sutro Biopharma's Enterprise Value averaged around -$262.2 million, with its median value being -$251.5 million (2023).
- Its Enterprise Value has fluctuated over the past 5 years, first crashed by 9089.27% in 2021, then skyrocketed by 5683.39% in 2025.
- Over the past 5 years, Sutro Biopharma's Enterprise Value (Quarter) stood at -$160.8 million in 2021, then tumbled by 88.08% to -$302.3 million in 2022, then decreased by 10.36% to -$333.7 million in 2023, then increased by 5.03% to -$316.9 million in 2024, then surged by 47.11% to -$167.6 million in 2025.
- Its Enterprise Value was -$167.6 million in Q3 2025, compared to -$205.1 million in Q2 2025 and -$249.0 million in Q1 2025.